60 Softgels ( SKU: 9606, NPN: 80036648 )
- The only full spectrum fresh-herb extract, standardized to contain Echinacea purpurea’s three active compounds – alkylamides, polysaccharides and cichoric acid
- Tested in two randomized, double-blind, placebo-controlled phase II clinical trials1,2
- Proven to reduce the severity and duration of upper respiratory infections, including the common cold by up to 75%
- Each 250 mg of EchinaMed is made from 2000 mg of hand-picked fresh Echinacea purpurea flower, leaves, stem and roots
- Certified organic echinacea from our farms in Canada’s Okanagan region
- Guaranteed pharmaceutical purity
- Guaranteed label strength
EchinaMed is the result of a highly sophisticated, patented extraction process that guarantees consistent levels of Echinacea purpurea’s three key active constituents – alkylamides, polysaccharides and cichoric acid. These active constituents are provided in a base of whole herb, so that none of the minor actives are missing. EchinaMed is the first echinacea extract that meets the rigorous scientific standards demanded of pharmaceuticals. It is the only extract tested in two randomized, double-blind, placebo controlled phase II clinical trials.1,2 These trials, as well as laboratory evidence, have demonstrated that EchinaMed is an effective stimulant of the innate immune system1,2,3,4 reducing the severity and duration of upper respiratory tract infections, and possibly mitigating the risk of secondary infections.1,2 EchinaMed has been found to increase the number of circulating white blood cells, monocytes, neutrophils and natural killer cells.2 In vivo animal studies have demonstrated an increase in alveolar macrophage phagocytic response in a dose-dependent manner, as well as increased nitric oxide and tumour necrosis factor alpha (TNF-α).3,4 Nitric oxide is one of the primary mechanisms by which alveolar macrophages destroy foreign particles in the lungs, while TNF-α has antiviral effects, accounting for EchinaMed’s ability to act both therapeutically and preventatively.
Serving Size: 1 Softgel
Servings per Container: 60
Each Softgel Contains:
EchinaMed® (Echinacea purpurea) Standardized Extract 2.9:1 (aerial, root) .............250 mg
(Equivalent to 725 mg Crude Herb)
Softgel (gelatin, glycerin, purified water, carob), sunflower oil, yellow beeswax, sunflower lecithin.
Contains no artificial colours, preservatives, or sweeteners; no dairy, starch, sugar, wheat, gluten, yeast, soy, corn, egg, fish, shellfish, salt, tree nuts, or GMOs. Sealed for your protection. Do not use if seal is broken. For freshness, store in a cool, dry place.
At the first sign of a viral infection, take 1 softgel 5 times per day for the first 2 days, then take 1 softgel 3 times per day on subsequent days for up to 21 days.
Preventative Use: For immune system support throughout the year, take 1 softgel per day or as directed by a health care practitioner. Consult a health care practitioner for use beyond 8 weeks.
Do not use if you are allergic to plants of the Asteraceae/Compositae/Daisy family. Herbs in this family include: ragweed, marigolds, daisies and chrysanthemums. Theoretical contraindication was suggested by the German Commission E5 surrounding the use of Echinacea species in autoimmune conditions, due to the immunostimulatory effects of the herb. Consult a health care practitioner prior to use if you have a progressive systemic disease, (e.g., tuberculosis, leucosis, collagenosis or multiple sclerosis), or if you are taking immunosuppressants; however, there is no clinical evidence to support this concern.5,6 The reason for the Commission’s caution was based on theoretical concerns and because such conditions are not amenable to self-medication.5 As such, caution may still be warranted.6 Hypersensitivity (e.g., allergy) has been known to occur, in which case discontinue use. Consult a health care practitioner if symptoms persist or worsen. Keep out of reach of children.
Due to the theoretical concern of E. purpurea use in autoimmune conditions, it has been suggested that patients using immunosuppressant drugs may need to exercise caution, as efficacy could be reduced. However, there is currently no clinical evidence to support this concern.5.6
- Goel V, Lovlin R, Barton R, Lyon MR, Bauer R, Lee TD, Basu TK. Efficacy of a standardized Echinacea preparation (Echinilin) for the treatment of the common cold: a randomized, double-blind, placebo-controlled trial. J Clin Pharm Ther. 2004 Feb;29(1):75-83.
- Goel V, Lovlin R, Chang C, Slama JV, Barton R, Gahler R, Bauer R, Goonewardene L, Basu TK. A proprietary extract from the Echinacea plant (Echinacea purpurea) enhances systemic immune response during a common cold. Phytother Res. 2005 Aug;19(8):689-94.
- Goel V, Chang C, Slama JV, Barton R, Bauer R, Gahler R, Basu TK. Alkylamides of Echinacea purpurea stimulate alveolar macrophage function in normal rats. Int Immunopharmacol. 2002 Feb;2(2-3):381-7.
- Goel V, Change C, Slama J, Baron R, Bauer R, Gahler R, Basu T. Echinacea stimulates macrophage function in the lung and spleen of normal rats. J Nutr Biochem. 2002 Aug;13(8):487.
- Blumenthal M, Busse WR, Goldberg A, et al. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Boston, American Botanical Council, 1998.
- Barrett B. Echinacea: Safety Review. Herbal-Gram. 2003;57;36-39.